| Ustekinumab as induction and maintenance therapy for ulcerative colitis BE Sands, WJ Sandborn, R Panaccione, CD O’Brien, H Zhang, J Johanns, ... New England Journal of Medicine 381 (13), 1201-1214, 2019 | 1146 | 2019 |
| Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab H Yanai, L Lichtenstein, A Assa, Y Mazor, B Weiss, A Levine, Y Ron, ... Clinical Gastroenterology and Hepatology 13 (3), 522-530. e2, 2015 | 368 | 2015 |
| Infliximab-related infusion reactions: systematic review L Lichtenstein, Y Ron, S Kivity, S Ben-Horin, E Israeli, GM Fraser, I Dotan, ... Journal of Crohn's and Colitis 9 (9), 806-815, 2015 | 245 | 2015 |
| Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon L Harrell, Y Wang, D Antonopoulos, V Young, L Lichtenstein, Y Huang, ... PloS one 7 (2), e32545, 2012 | 171 | 2012 |
| Translational inhibition of colonic epithelial heat shock proteins by IFN-γ and TNF-α in intestinal inflammation S Hu, MJ Ciancio, M Lahav, M Fujiya, L Lichtenstein, S Anant, MW Musch, ... Gastroenterology 133 (6), 1893-1904, 2007 | 115 | 2007 |
| Efficacy and safety of vedolizumab for induction of remission in inflammatory bowel disease - the Israeli experience U Kopylov, Y Ron, I Biron, B Koslovsky, M Waterman, S Daher, B Ungar, ... United European Gastroenterology Journal 2 (Supplement 1), 2016 | 111* | 2016 |
| Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα H Edelman-Klapper, E Zittan, ABG Shitrit, KM Rabinowitz, I Goren, ... Gastroenterology 162 (2), 454-467, 2022 | 91 | 2022 |
| Probiotics and prebiotics in Crohn's disease therapies L Lichtenstein, I Avni-Biron, O Ben-Bassat Best Practice & Research Clinical Gastroenterology 30 (1), 81-88, 2016 | 86 | 2016 |
| Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins S Hu, Y Wang, L Lichtenstein, Y Tao, MW Musch, B Jabri, D Antonopoulos, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 299 (6 …, 2010 | 63 | 2010 |
| Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer Y Tao, J Hart, L Lichtenstein, LJ Joseph, MJ Ciancio, S Hu, EB Chang, ... Carcinogenesis 30 (1), 175-182, 2009 | 51 | 2009 |
| Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development K Uchiyama, T Sakiyama, T Hasebe, MW Musch, H Miyoshi, Y Nakagawa, ... Scientific reports 6 (1), 32094, 2016 | 38 | 2016 |
| Inflammation-induced, 3′ UTR-dependent translational inhibition of Hsp70 mRNA impairs intestinal homeostasis S Hu, X Zhu, JR Triggs, Y Tao, Y Wang, L Lichtenstein, M Bissonnette, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 296 (5 …, 2009 | 38 | 2009 |
| Long-term treatment outcome of patients with gastric vascular ectasia treated with argon plasma coagulation D Boltin, R Gingold-Belfer, L Lichtenstein, Z Levi, Y Niv European Journal of Gastroenterology & Hepatology 26 (6), 588-593, 2014 | 36 | 2014 |
| Capsule endoscopy crohn's disease activity index (CDEAIIC or Niv score) for the small bowel and the colon. Y Niv, M Hershkovitz, L Lichtenstein, V Gabovitz, A I United European Gastroenterology Journal 2 (Supplement 1), 2016 | 29 | 2016 |
| Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells JS Delgado, R Mustafi, J Yee, S Cerda, A Chumsangsri, U Dougherty, ... Digestive diseases and sciences 53, 3055-3064, 2008 | 28 | 2008 |
| The current place of probiotics and prebiotics in the treatment of pouchitis L Lichtenstein, I Avni-Biron, O Ben-Bassat Best Practice & Research Clinical Gastroenterology 30 (1), 73-80, 2016 | 27 | 2016 |
| I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 25 | 2023 |
| Quality of life and uncertainty in Crohn’s disease G Niv, S Bar Josef, O Ben Bassat, I Avni, Y Niv, S Barnoy Quality of Life Research 26, 1609-1616, 2017 | 25 | 2017 |
| Anti-TNFα treatment impairs long-term immune responses to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases KM Rabinowitz, M Navon, H Edelman-Klapper, E Zittan, A Bar-Gil Shitrit, ... Vaccines 10 (8), 1186, 2022 | 13 | 2022 |
| Correlation of 18F‐FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn’s Disease: A Pilot Study L Domachevsky, H Leibovitzh, I Avni-Biron, L Lichtenstein, N Goldberg, ... Contrast media & molecular imaging 2017 (1), 7167292, 2017 | 12 | 2017 |
Eugene ChangUniversity of Chicago在 medicine.bsd.uchicago.edu 的电子邮件经过验证
